Interaction of Brucella suis and Brucella abortus rough strains with human dendritic cells

Infection and Immunity

Volumn 75, Issue 12, 2007, Pages 5916-5923

  Billard, Elisabeth ^a,b   Dornand, Jacques ^a,b   Gross, Antoine ^a,b  

^a University of Montpellier I and II   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BRUCELLA ABORTUS; BRUCELLA SUIS; BRUCELLOSIS; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL MATURATION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFECTION SENSITIVITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

BRUCELLA ABORTUS; BRUCELLA SUIS; DENDRITIC CELLS; HUMANS; INTERLEUKIN-12; LIPOPOLYSACCHARIDES; O ANTIGENS; T-LYMPHOCYTES; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36749071446     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00931-07     Document Type: Article

References (55)

1. Aragon, V., R. Diaz, E. Moreno, and I. Moriyon. 1996. Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J. Bacteriol. 178:1070-1079.
2. Baldwin, C. L., and R. Goenka. 2006. Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection? Crit. Rev. Immunol. 26:407-442.
3. Ben Nasr, A., J. Haithcoat, J. E. Masterson, J. S. Gunn, T. Eaves-Pyles, and G. R. Klimpel. 2006. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria. J. Leukoc. Biol. 80:774-786.
4. Billard, E., C. Cazevieille, J. Dornand, and A. Gross. 2005. High susceptibility of human dendritic cells to invasion by the intracellular pathogens Brucella suis, B. abortus, and B. melitensis. Infect. Immun. 73:8418-8424.
5. Billard, E., J. Dornand, and A. Gross. 2007. Brucella suis prevents human dendritic cell maturation and antigen presentation through regulation of tumor necrosis factor alpha secretion. Infect. Immun. 75:4980-4989.
6. Boschiroli, M. L., S. Ouahrani-Bettache, V. Foulongne, S. Michaux-Charachon, G. Bourg, A. Allardet-Servent, C. Cazevieille, J. P. Liautard, M. Ramuz, and D. O'Callaghan. 2002. The Brucella suis virB operon is induced intracellularly in macrophages. Proc. Natl. Acad. Sci. USA 99:1544-1549.
7. Bosio, C. M., and S. W. Dow. 2005. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 175:6792-6801.
8. Briones, G., N. Inon de Iannino, M. Reset, A. Vigliocco, P. S. Paulo, and R. A. Ugalde. 2001. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells. Infect. Immun. 69:4528-4535.
9. Campos, M. A., G. M. S. Rosinha, I. C. Almeida, X. S. Salgueiro, B. W. Jarvis, G. A. Splitter, N. Qureshi, O. Bruna-Romero, R. T. Gazzinelli, and S. C. Oliveira. 2004. Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice. Infect. Immun. 72:176-186.
10. Celli, J., C. de Chastellier, D. M. Franchini, J. Pizarro-Cerda, E. Moreno, and J. P. Gorvel. 2003. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med. 198:545-556.
11. Celli, J. 2006. Surviving inside a macrophage: the many ways of Brucella. Res. Microbiol. 157:93-98.
12. Cloeckaert, A., J. M. Verger, M. Grayon, and N. Vizcaino. 1996. Molecular and immunological characterization of the major outer membrane proteins of Brucella. FEMS Microbiol. Lett. 145:1-8.
13. Cloeckaert, A., M. S. Zygmunt, G. Bezard, and G. Dubray. 1996. Purification and antigenic analysis of the major 25-kilodalton outer membrane protein of Brucella abortus. Res. Microbiol. 147:225-235.
14. Copin, R., P. De Baetselier, Y. Carlier, J. J. Letesson, and E. Muraille. 2007. Myd88-dependent activation of B220-CD11b+LY-6C+ dendritic cells during Brucella melitensis infection. J. Immunol. 178:5182-5191.
15. de Jong, E. C., H. H. Smits, and M. L. Kapsenberg. 2005. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26:289-307.
16. Delrue, R. M., M. Martinez-Lorenzo, P. Lestrate, I. Danese, V. Bielarz, P. Mertens, X. De Bolle, A. Tibor, J. P. Gorvel, and J. J. Letesson. 2001. Identification of Brucella spp. genes involved in intracellular trafficking. Cell. Microbiol. 3:487-497.
17. Fernandez-Prada, C. M., M. Nikolich, R. Vemulapalli, N. Sriranganathan, S. M. Boyle, G. G. Schurig, T. L. Hadfield, and D. L. Hoover. 2001. Deletion of wboA enhances activation of the lectin pathway of complement in Brucella abortus and Brucella melitensis. Infect. Immun. 69:4407-4416.
18. Forestier, C., E. Moreno, J. Pizarro-Cerda, and J. P. Gorvel. 1999. Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J. Immunol. 162:6784-6791.
19. Forestier, C., F. Deleuil, N. Lapaque, E. Moreno, and J. P. Gorvel. 2000. Brucella abortus lipopolysaccharide in murine peritoneal macrophages acts as a down-regulator of T cell activation. J. Immunol. 165:5202-5210.
20. Freer, E., E. Moreno, I. Moriyoń, J. Pizarro-Cerdá, A. Weintraub, and J.-P. Gorvel. 1996. Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J. Bacteriol. 178:5867-5876.
21. Freer, E., J. Pizarro-Cerda, A. Weintraub, J. A. Bengoechea, I. Moriyon, K. Hultenby, J. P. Gorvel, and E. Moreno. 1999. The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect. Immun. 67:6181-6186.
22. Giambartolomei, G. H., M. V. Delpino, M. E. Cahanovich, J. C. Wallach, P. C. Baldi, C. A. Velikovsky, and C. A. Fossati. 2002. Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis. J. Infect. Dis. 186:252-259.
23. Godfroid, J., A. Cloeckaert, J. Liautard, S. Kohler, D. Fretin, K. Walravens, B. Garin-Bastuji, and J. Letesson. 2005. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet. Res. 36:313-326.
24. Goldstein, J., T. Hoffman, C. Frasch, E. F. Lizzio, P. R. Beining, D. Hochstein, Y. L. Lee, R. D. Angus, and B. Golding. 1992. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect. Immun. 60:1385-1389.
25. Gross, A., M. Bouaboula, P. Casellas, J. P. Liautard, and J. Dornand. 2003. Subversion and utilization of the host cell cyclic adenosine 5′-monophosphate/protein kinase A pathway by Brucella during macrophage infection. J. Immunol. 170:5607-5614.
26. Gross, A., S. Spiesser, A. Terraza, B. Rouot, E. Caron, and J. Dornand. 1998. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect. Immun. 66:1309-1316.
27. Jarvis, B. W., T. H. Harris, N. Qureshi, and G. A. Splitter. 2002. Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells. Infect. Immun. 70:7165-7168.
28. Jimenez de Bagues, M. P., A. Gross, A. Terraza, and J. Dornand. 2005. Regulation of the mitogen-activated protein kinases by Brucella spp. expressing a smooth and rough phenotype: relationship to pathogen invasiveness. Infect. Immun. 73:3178-3183.
29. Jimenez de Bagues, M. P., A. Terraza, A. Gross, and J. Dornand. 2004. Different responses of macrophages to smooth and rough Brucella spp.: relationship to virulence. Infect. Immun. 72:2429-2433.
30. Jiménez de Bagüés, M. P., P. H. Elzer, S. M. Jones, J. M. Blasco, F. M. Enright, G. G. Schurig, and A. J. Winter. 1994. Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infect. Immun. 62:4990-4996.
31. Jimenez de Bagues, M. P., S. Dudal, J. Dornand, and A. Gross. 2005. Cellular bioterrorism: how Brucella corrupts macrophage physiology to promote invasion and proliferation. Clin. Immunol. 114:227-238.
32. Jubier-Maurin, V., R.-A. Boigegrain, A. Cloeckaert, A. Gross, M.-T. Alvarez-Martinez, A. Terraza, J. Liautard, S. Kohler, B. Rouot, J. Dornand, and J. P. Liautard. 2001. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect. Immun. 69:4823-4830.
33. Ko, J., and G. A. Splitter. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 16:65-78.
34. Lapaque, N., F. Forquet, C. de Chastellier, Z. Mishal, G. Jolly, E. Moreno, I. Moriyon, J. E. Heuser, H. He, and J. Gorvel. 2006. Characterization of Brucella abortus lipopolysaccharide macrodomains as mega rafts. Cell. Microbiol. 8:197-206.
35. Martinez de Tejada, G., J. Pizarro-Cerda, E. Moreno, and I. Moriyon. 1995. The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect. Immun. 63:3054-3061.
36. Moriyon, I., M. J. Grille, D. Monreal, D. Gonzalez, C. Marin, I. Lopez-Goni, R. C. Mainar-Jaime, E. Moreno, and J. M. Blasco. 2004. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet. Res. 35:1-38.
37. Pappas, G., P. Panagopoulou, L. Christou, and N. Akritidis. 2006. Brucella as a biological weapon. Cell. Mol. Life Sci. 63:2229-2236.
38. Pizarro-Cerdá, J., M. Desjardins, E. Moreno, S. Akira, and J. P. Gorvel. 1999. Modulation of endocytosis in nuclear factor IL-6(-/-) macrophages is responsible for a high susceptibility to intracellular bacterial infection. J. Immunol. 162:3519-3526.
39. Porte, F., A. Naroeni, S. Ouahrani-Bettache, and J. P. Liautard. 2003. Role of the Brucella suis lipopolysaccharide O antigen in phagosomal genesis and in inhibition of phagosome-lysosome fusion in murine macrophages. Infect. Immun. 71:1481-1490.
40. Rafiei, A., S. K. Ardestani, A. Kariminia, A. Keyhani, M. Mohraz, and A. Amirkhani. 2006. Dominant Th1 cytokine production in early onset of human brucellosis followed by switching towards Th2 along prolongation of disease. J. Infect. 53:315-324.
41. Randolph, G. J., G. Sanchez-Schmitz, and V. Angeli. 2005. Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin. Immunopathol. 26:273-287.
42. Rasool, O., E. Freer, E. Moreno, and C. Jarstrand. 1992. Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils. Infect. Immun. 60:1699-1702.
43. Ritter, U., A. Meissner, J. Ott, and H. Korner. 2003. Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF. J. Leukoc. Biol. 74:216-222.
44. Rittig, M. G., A. Kaufmann, A. Robins, B. Shaw, H. Sprenger, D. Gemsa, V. Foulongne, B. Rouot, and J. Dornand. 2003. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J. Leukoc. Biol. 74:1045-1055.
45. Sathiyaseelan, J., R. Goenka, M. Parent, R. M. Benson, E. A. Murphy, D. Fernandesa, A. S. Foulkes, and C. L. Baldwin. 2006. Treatment of Brucella-susceptible mice with IL-12 increases primary and secondary immunity. Cell. Immunol. 243:1-9.
46. Schaible, U. E., and S. H. Kaufmann. 2000. CD1 and CD1-restricted T cells in infections with intracellular bacteria. Trends Microbiol. 8:419-425.
47. Schurig, G. G., N. Sriranganathan, and M. J. Corbel. 2002. Brucellosis vaccines: past, present and future. Vet. Microbiol. 90:479-496.
48. Scott, K., M. Manunta, C. Germain, P. Smith, M. Jones, P. Mitchell, D. Dessi, K. B. Bamford, R. I. Lechler, P. L. Fiori, G. R. Foster, and G. Lombardi. 2005. Qualitatively distinct patterns of cytokines are released by human dendritic cells in response to different pathogens. Immunology 116:245-254.
49. Shannon, J. G., D. Howe, and R. A. Heinzen. 2005. Virulent Coxiella burnetii does not activate human dendritic cells: role of lipopolysaccharide as a shielding molecule. Proc. Natl. Acad. Sci. USA 102:8722-8727.
50. Sicard, M., K. Brugirard-Ricaud, S. Pagès, A. Lanois, N. E. Boemare, M. Brehélin, and A. Givaudan. 2004. Stages of infection during the tripartite interaction between Xenorhabdus nematophila, its nematode vector, and insect hosts. Appl. Environ. Microbiol. 70:6473-6480.
51. Trevejo, J. M., M. W. Marino, N. Philpott, R. Josien, E. C. Richards, K. B. Elkon, and E. Falck-Pedersen. 2001. TNF-alpha-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc. Natl. Acad. Sci. USA 98:12162-12167.
52. Vemulapalli, R., Y. He, S. M. Boyle, N. Sriranganathan, and G. G. Schurig. 2000. Brucella abortus strain RB51 as a vector for heterologous protein expression and induction of specific Th1-type immune responses. Infect. Immun. 68:3290-3296.
53. Weiss, D. S., K. Takeda, S. Akira, A. Zychlinsky, and E. Moreno. 2005. Myd88, but not Toll-like receptors 4 and 2, is required for efficient clearance of Brucella abortus. Infect. Immun. 73:5137-5143.
54. Zhan, Y., and C. Cheers. 1998. Control of IL-12 and IFN-gamma production in response to live or dead bacteria by TNF and other factors. J. Immunol. 161:1447-1453.
55. Zhan, Y., Z. Liu, and C. Cheers. 1996. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect. Immun. 64:2782-2786.